+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Disease Analysis: Hepatocellular Carcinoma (HCC) - Product Thumbnail Image

Disease Analysis: Hepatocellular Carcinoma (HCC)

  • Report
  • April 2021
  • 73 Pages
  • Global
Market Spotlight: Chemotherapy-Induced Anemia - Product Thumbnail Image

Market Spotlight: Chemotherapy-Induced Anemia

  • Report
  • February 2021
  • 32 Pages
  • Global
Market Spotlight: Myelodysplastic Syndrome (MDS) - Product Thumbnail Image

Market Spotlight: Myelodysplastic Syndrome (MDS)

  • Report
  • February 2021
  • 60 Pages
  • Global
Market Spotlight: Small-Cell Lung Cancer (SCLC) - Product Thumbnail Image

Market Spotlight: Small-Cell Lung Cancer (SCLC)

  • Report
  • November 2020
  • 49 Pages
  • Global
Market Spotlight: Basal Cell Carcinoma (2020) - Product Thumbnail Image

Market Spotlight: Basal Cell Carcinoma (2020)

  • Report
  • March 2020
  • 33 Pages
  • Global
Opdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) Drug Overview 2019 - Product Thumbnail Image

Opdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 118 Pages
  • Global
Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019 - Product Thumbnail Image

Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 141 Pages
  • Global
Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019 - Product Thumbnail Image

Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019

  • Report
  • September 2019
  • 29 Pages
  • Global
Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019 - Product Thumbnail Image

Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019

  • Report
  • September 2019
  • 28 Pages
  • Global
Bavencio (avelumab; Merck KGaA/Pfizer) Drug Overview 2019 - Product Thumbnail Image

Bavencio (avelumab; Merck KGaA/Pfizer) Drug Overview 2019

  • Drug Pipelines
  • March 2019
  • 86 Pages
  • Global
Inlyta (axitinib; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Inlyta (axitinib; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 20 Pages
  • Global
Sutent (sunitinib; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Sutent (sunitinib; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 19 Pages
  • Global
Venclexta - Product Thumbnail Image

Venclexta

  • Report
  • January 2019
  • 45 Pages
  • Global
From
Treanda/Bendeka - Product Thumbnail Image

Treanda/Bendeka

  • Report
  • January 2019
  • 58 Pages
  • Global
From
Aliqopa - Product Thumbnail Image

Aliqopa

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Kymriah - Product Thumbnail Image

Kymriah

  • Report
  • January 2019
  • 38 Pages
  • Global
From
Imbruvica - Product Thumbnail Image

Imbruvica

  • Report
  • January 2019
  • 51 Pages
  • Global
From
Gazyva - Product Thumbnail Image

Gazyva

  • Report
  • January 2019
  • 40 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more